Patent Assignment
Reel/Frame 064818/0478
Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assests into Darwin Molecular Corporation
Recorded: 2023-09-04
Pages: 8
Assignor
CELLTECH R&D, INC.
Executed: 2004-12-28
Assignee
DARWIN MOLECULAR CORPORATION
1631 220TH STREET S.E., BOTHELL, WASHINGTON, 98201
Covered Property
(1)
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application:
18/333,425 →
Publication:
US 2024/0209075
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 4, 2023
From: WINKLER, DAVID G.; SHI, JIYE; LATHAM, JOHN
To: CELLTECH R&D, INC.
Reel/Frame 064786/0724 →
Merger
Sep 4, 2023
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 064786/0765 →
Assignment of Assignor's Interest
Sep 4, 2023
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 064786/0781 →